Menu
Close
.svg)
One of the more interesting conversations (in some cases, debates) we’ve been having with clients lately as Habit Lens continues to gain traction around the industry is around the distinction between habit and loyalty. These two terms often are used interchangeably in the context of marketing conversation, but I’ve increasingly come to believe they are related -- yet fundamentally different -- concepts.
Loyalty, in my view, is primarily an attitude. Habit is a behavior.
A physician may say she is loyal to a brand because she trusts it, feels comfortable with it, has had good experiences with it, and/or learned to use it effectively during training. Those are important things. But loyalty alone does not necessarily mean the product has become automatic.
Habit is different. It is about behavioral automaticity.
Habit is when the decision has, in many respects, already been made.
It is the physician who instinctively reaches for the same medication in a recognizable patient situation (i.e., what we call a "cue"). It is the patient who refills the same medication without deeply reconsidering alternatives every month. It is the behavioral pathway that has become so reinforced through repetition, workflow integration, familiarity, and favorable feedback that the choice itself begins to require less (or no) active deliberation.
In that sense, habit is loyalty behavior.
The two concepts overlap considerably, of course. Strong loyalty can reinforce habit, and repeated habitual use can deepen emotional loyalty over time. But I do not think they are identical.
One reason this distinction matters is because traditional pharmaceutical marketing research has historically focused much more heavily on attitudinal constructs:
These are all important metrics. But they do not always tell us whether the brand has become embedded into the physician’s or patient’s behavioral routine.
And in the real world, routine typically wins.
A physician may express admiration for a new therapy yet continue prescribing the older product she has used for years because it fits seamlessly into her workflow, her treatment heuristics, and her accumulated clinical experience. The habit remains stronger than the attitude shift.
This is one reason I believe behavioral science, and more specifically understanding habit formation, is becoming increasingly important in healthcare strategy. We need to better distinguish between what customers say they value and what they actually do automatically under real-world conditions of time pressure, complexity, and cognitive overload.
In many therapeutic categories, especially mature ones, the “go-to” product often has less to do with active preference than with deeply ingrained behavioral familiarity. The product fits the physician’s routines. It feels operationally frictionless. The outcomes are predictable. The workflow complexity and barriers are low. Confidence has accumulated over years of repeated use.
Those are habit dynamics.
And importantly, they may persist even when attitudes begin shifting elsewhere.
The strongest brands, in my opinion, ultimately achieve both:
They become trusted. And they become routine.
That concoction is extraordinarily powerful.
I’m curious how others in behavioral science, marketing strategy, and I&A think about this distinction. Is habit simply the behavioral manifestation of loyalty? Or are they separate systems that only partially overlap?
